Delivery Order SPE2DB24D1205-SPE2DB24FCSGN

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,455.93 and an ultimate completion date of January 3, 2025. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription pharmaceutical product. The award has a ceiling value of $5,090.48 and a completion date of July 2, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is structured as a Delivery Order under a Firm Fixed Price contract type. This award is not associated with a set-aside designation. Amerisourcebergen Drug...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of VYVANSE 50 MG CAPSULE 100S. The award has a ceiling value of $1,427.48 and is a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.67 Firm Fixed Price Delivery Order contract is for the supply of 4567394215 ! VYVANSE 70 MG CAPSULE 100S. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the provision of VYVANSE 70 MG CAPSULE 100S. The $1,929.46 firm fixed-price delivery order has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,276.50, has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this contract without any set-aside designation, indicating it was a full and open competition. The...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of VYVANSE CAPS 50MG, a pharmaceutical product, and has a ceiling value of $34,354.33. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance runs through January 24, 2025. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of VYVANSE CAPS 50MG, a pharmaceutical product, with a ceiling value of $16,577.70 and a period of performance through April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $1,068.99 and is set to expire on April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSGN
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,677.39 and an ultimate completion date of June 27, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/25/24, 9:23 AM